• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eurosurv. Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022

tetano

Editor, Senior Moderator
Matilda Berkell[SUP]1,2,*[/SUP] ORCID icon, Anna Górska[SUP]3,*[/SUP] , Mathias Smet[SUP]1,2,*[/SUP] , Delphine Bachelet[SUP]4,5,*[/SUP] , Elisa Gentilotti[SUP]3,**[/SUP] , Mariana Guedes[SUP]3,**[/SUP] , Anna Maria Franco-Yusti[SUP]4,6,**[/SUP] , Fulvia Mazzaferri[SUP]3[/SUP] , Erley Lizarazo Forero[SUP]7[/SUP] , Veerle Matheeussen[SUP]1[/SUP] , Benoit Visseaux[SUP]6[/SUP] , Zaira R. Palacios-Baena[SUP]8,9[/SUP] , Natascia Caroccia[SUP]10,11[/SUP] , Aline-Marie Florence[SUP]4,5[/SUP] , Charlotte Charpentier[SUP]4,6[/SUP] , Coretta van Leer[SUP]7[/SUP] , Maddalena Giannella[SUP]10,11[/SUP] , Alex W. Friedrich[SUP]7[/SUP] , Jesús Rodríguez-Baño[SUP]8,9[/SUP] , Jade Ghosn[SUP]4,12[/SUP] , ORCHESTRA working group[SUP]13[/SUP] , Samir Kumar-Singh[SUP]1,2[/SUP] , Cedric Laouénan[SUP]4,5[/SUP] , Evelina Tacconelli[SUP]3,***[/SUP] , Surbhi Malhotra-Kumar[SUP]1,**[/SUP]​

Background

Evolution of SARS-CoV-2 is continuous.

Aim

Between 01/2020 and 02/2022, we studied SARS-CoV-2 variant epidemiology, evolution and association with COVID-19 severity.

Methods

In nasopharyngeal swabs of COVID-19 patients (n = 1,762) from France, Italy, Spain, and the Netherlands, SARS-CoV-2 was investigated by reverse transcription-quantitative PCR and whole-genome sequencing, and the virus variant/lineage (NextStrain/Pangolin) was determined. Patients’ demographic and clinical details were recorded. Associations between mild/moderate or severe COVID-19 and SARS-CoV-2 variants and patient characteristics were assessed by logistic regression. Rates and genomic locations of mutations, as well as quasi-species distribution (≥ 2 heterogeneous positions, ≥ 50× coverage) were estimated based on 1,332 high-quality sequences.

Results

Overall, 11 SARS-CoV-2 clades infected 1,762 study patients of median age 59 years (interquartile range (IQR): 45–73), with 52.5% (n = 925) being male. In total, 101 non-synonymous substitutions/insertions correlated with disease prognosis (severe, n = 27; mild-to-moderate, n = 74). Several hotspots (mutation rates ≥ 85%) occurred in Alpha, Delta, and Omicron variants of concern (VOCs) but none in pre-Alpha strains. Four hotspots were retained across all study variants, including spike:D614G. Average number of mutations per open-reading-frame (ORF) increased in the spike gene (average < 5 per genome in January 2020 to > 15 in 2022), but remained stable in ORF1ab, membrane, and nucleocapsid genes. Quasi-species were most prevalent in 20A/EU2 (48.9%), 20E/EU1 (48.6%), 20A (38.8%), and 21K/Omicron (36.1%) infections. Immunocompromised status and age (≥ 60 years), while associated with severe COVID-19 or death irrespective of variant (odds ratio (OR): 1.60–2.25; p ≤ 0.014), did not affect quasi-species’ prevalence (p > 0.05).

Conclusion

Specific mutations correlate with COVID-19 severity. Quasi-species potentially shaping VOCs’ emergence are relevant to consider.





https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.10.2400038
 
Back
Top Bottom